YDES — YD Bio Ltd
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 2011674 ·
Taiwan
Last close
$4.73
Market Cap
$335.03M
52W High
$15.72
52W Low
$1.70
ADV30
104,147
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 10,060,261 | 2,662,004 | 5,586,292 |
| Dec 2025 | — | — | — | — | 13,779,397 | 6,007,615 | 16,635,060 |
| Jun 2025 | — | — | — | — | 5,841,086 | 469,520 | 752,935 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-3,537,862
Inventory
$1,892,355
Receivables
$558,863
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$510,360
EBITDA
$-1,357,195
Free Cash Flow
$-3,875,569
Enterprise Value
$2,657,031
Total Cash
$3,132,298
Total Debt
$22,265
Shares Out
70,831,346
Trailing EPS
$0.00
Book Value
$4.57
ROE
-42.7%
ROA
-25.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 596,817 | -5,268,318 | -8,311,316 | 13,779,397 | 16,635,060 | -2,855,663 | -6,596,706 |
| Dec 2024 | 510,360 | -1,462,423 | -1,411,559 | 6,864,226 | 273,980 | 6,590,246 | -1,222,681 |
| Dec 2023 | 350,131 | -7,116 | 13,560 | 321,212 | 298,218 | 22,994 | -55,657 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VMD | VIEMED HEALTHCARE, INC. | $343.69M | $9.07 | — |
| STLN | Starling Oncology, Inc. | $346.51M | $3.40 | — |
| CYH | COMMUNITY HEALTH SYSTEMS INC | $284.87M | $2.02 | — |
| DFPH | Starling Oncology, Inc. | $436.37M | $2.01 | — |
| MCTA | Charming Medical Ltd | $445.55M | $29.35 | — |
News headlines (Yahoo Finance, 1h cache)
YD Bio Limited Reports Full Year 2025 Financial Results
2026-04-30 22:00 · Yahoo
YD Bio Announces FDA Grant of INTERACT Meeting Request for YDB-LMSCEV-001, an Investigational Extracellular Vesicle Candidate for Dry Eye Disease
2026-11-12 21:30 · Yahoo
YD Bio and EG BioMed Partner with JoiiUp to Launch AI-Driven Cancer Risk Assessment for Corporate Wellness Programs
2026-10-20 12:00 · Yahoo
YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
2026-10-06 12:00 · Yahoo
YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future
2026-08-11 12:00 · Yahoo
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research
2026-08-04 12:00 · Yahoo
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
2026-07-28 12:00 · Yahoo
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services
2026-07-23 12:00 · Yahoo
YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
2026-08-31 22:00 · Yahoo
YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
2026-08-25 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.